Greenphire CEO Selected as Finalist in Ernst & Young Awards
News May 17, 2013
The awards recognize entrepreneurs that create and build market-leading businesses, taking standards of excellence to new heights and helping to transform the face of their respective industries. Sam was chosen from over 70 executives as a finalist for his achievements in building Greenphire into an industry leader.
Sam Whitaker, CEO of Greenphire, comments, "I am delighted to have been selected as a finalist by Ernst & Young and to be honored along with fellow nominees. As Greenphire grows and expands internationally, it is gratifying to be recognized for our successes in transforming outdated processes in the clinical trials industry. It would not have been possible without the tireless work of all the team members at Greenphire."
Since founding Greenphire, Sam has leveraged his entrepreneurial vision to simplify processes within clinical studies, replacing burdensome manual methods with platform-driven tools that execute complex payment processes globally. In five years he has built Greenphire from a two-person concept-driven start-up to an established player in the industry. The company now employs approximately 50 people on two continents.
Awards will be presented at a black tie gala on June 20 at the Pennsylvania Convention Center.
Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain CancerNews
Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.READ MORE
XenoGesis and Juniper Pharma Services Strengthen AllianceNews
Campanies extend strategic alliance in early drug development services.READ MORE
Quotient Clinical Signs Cocrystal Agreement with NuformixNews
Partnership to evaluate cocrystal formulations using translational pharmaceutics.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018